118 related articles for article (PubMed ID: 25665518)
1. 2,3-Dihydroquinazolin-4(1H)-one derivatives as potential non-peptidyl inhibitors of cathepsins B and H.
Singh M; Raghav N
Bioorg Chem; 2015 Apr; 59():12-22. PubMed ID: 25665518
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and docking studies of bischalcones based quinazoline-2(1H)-ones and quinazoline-2(1H)-thiones derivatives as novel inhibitors of cathepsin B and cathepsin H.
Raghav N; Singh M
Eur J Pharm Sci; 2014 Apr; 54():28-39. PubMed ID: 24412851
[TBL] [Abstract][Full Text] [Related]
3. 2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.
Garg S; Raghav N
Bioorg Chem; 2016 Aug; 67():64-74. PubMed ID: 27285276
[TBL] [Abstract][Full Text] [Related]
4. Acyl hydrazides and triazoles as novel inhibitors of mammalian cathepsin B and cathepsin H.
Raghav N; Singh M
Eur J Med Chem; 2014 Apr; 77():231-42. PubMed ID: 24642566
[TBL] [Abstract][Full Text] [Related]
5. Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.
Raghav N; Jangra S; Kumar A; Bhattacharyya S
Int J Biol Macromol; 2017 Jan; 94(Pt A):719-727. PubMed ID: 27780761
[TBL] [Abstract][Full Text] [Related]
6. SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.
Raghav N; Singh M
Bioorg Med Chem; 2014 Aug; 22(15):4233-45. PubMed ID: 24913985
[TBL] [Abstract][Full Text] [Related]
7. SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents.
Raghav N; Singh M
Bioorg Chem; 2017 Dec; 75():38-49. PubMed ID: 28915464
[TBL] [Abstract][Full Text] [Related]
8. Some thiocarbamoyl based novel anticathepsin agents.
Kaur R; Raghav N
Bioorg Chem; 2020 Nov; 104():104174. PubMed ID: 32932119
[TBL] [Abstract][Full Text] [Related]
9. N-formylpyrazolines and N-benzoylpyrazolines as novel inhibitors of mammalian cathepsin B and cathepsin H.
Raghav N; Garg S
Bioorg Chem; 2014 Dec; 57():43-50. PubMed ID: 25181676
[TBL] [Abstract][Full Text] [Related]
10. SAR studies of o-hydroxychalcones and their cyclized analogs and study them as novel inhibitors of cathepsin B and cathepsin H.
Raghav N; Garg S
Eur J Pharm Sci; 2014 Aug; 60():55-63. PubMed ID: 24780403
[TBL] [Abstract][Full Text] [Related]
11. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
Azaryan AV; Hook VY
Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
[TBL] [Abstract][Full Text] [Related]
12. Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5-triazin-2(1H)-ones as inhibitors of cathepsin B.
Sosič I; Mirković B; Turk S; Štefaneb B; Kos J; Gobec S
Eur J Med Chem; 2011 Sep; 46(9):4648-56. PubMed ID: 21849222
[TBL] [Abstract][Full Text] [Related]
13. Natural biflavones as novel inhibitors of cathepsin B and K.
Zeng GZ; Pan XL; Tan NH; Xiong J; Zhang YM
Eur J Med Chem; 2006 Nov; 41(11):1247-52. PubMed ID: 16828525
[TBL] [Abstract][Full Text] [Related]
14. Chalcones, semicarbazones and pyrazolines as inhibitors of cathepsins B, H and L.
Raghav N; Kaur R
Int J Biol Macromol; 2015 Sep; 80():710-24. PubMed ID: 26193682
[TBL] [Abstract][Full Text] [Related]
15. Irreversible inhibition of human cathepsins B, L, S and K by hypervalent tellurium compounds.
Cunha RL; Gouvêa IE; Feitosa GP; Alves MF; Brömme D; Comasseto JV; Tersariol IL; Juliano L
Biol Chem; 2009 Nov; 390(11):1205-12. PubMed ID: 19663682
[TBL] [Abstract][Full Text] [Related]
16. Study on enhanced serum protein protecting and anti-cathepsin activities of various curcumin formulations containing traditional excipients and bio-enhancers.
Raghav N; Mor N
Bioorg Chem; 2020 Nov; 104():104177. PubMed ID: 32919129
[TBL] [Abstract][Full Text] [Related]
17. Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B.
Mendieta L; Picó A; Tarragó T; Teixidó M; Castillo M; Rafecas L; Moyano A; Giralt E
ChemMedChem; 2010 Sep; 5(9):1556-67. PubMed ID: 20652927
[TBL] [Abstract][Full Text] [Related]
18. Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design.
Ménard R; Therrien C; Lachance P; Sulea T; Qo H; Alvarez-Hernandez AD; Roush WR
Biol Chem; 2001 May; 382(5):839-45. PubMed ID: 11517939
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel quinazolin-4(3H)-ones as inhibitors of thermolysin, the prototype of the M4 family of proteinases.
Khan MT; Khan R; Wuxiuer Y; Arfan M; Ahmed M; Sylte I
Bioorg Med Chem; 2010 Jun; 18(12):4317-27. PubMed ID: 20494587
[TBL] [Abstract][Full Text] [Related]
20. Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F.
Frizler M; Schmitz J; Schulz-Fincke AC; Gütschow M
J Med Chem; 2012 Jun; 55(12):5982-6. PubMed ID: 22686657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
